Pregled bibliografske jedinice broj: 710735
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results // Central European journal of public health, 16 (2008), 99-105 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 710735 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results
Autori
Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, et al. (Group Authors: EuroSIDA …Begovac Josip ; ….)
Izvornik
Central European journal of public health (1210-7778) 16
(2008);
99-105
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Adult; Anti-Retroviral Agents/ therapeutic use; Cohort Studies; Europe/epidemiology; Female; HIV Infections/ drug therapy/epidemiology; HIV-1/ drug effects; Humans; Male; Middle Aged; Prospective Studies. Treatment Outcome
Sažetak
EuroSIDA is a pan-European observational study that follows 14, 265 HIV-infected patients from 31 European countries, Israel and Argentina, of which 2, 560 are patients from eastern Europe (EE). The study group has performed several analyses addressing regional differences in the HIV-epidemic across Europe, where all countries were divided into five regions: south, west central, north, east central Europe and EE. Significant regional differences in patients' characteristics and pattern of AIDS diagnoses were documented. More patients from EE were diagnosed with tuberculosis compared to other regions. Significantly fewer HIV-infected patients in EE, who fulfilled the criteria for starting combination antiretroviral therapy (cART), actually received cART as compared with other regions of Europe. Those, receiving cART in EE had a lower initial virologic response rate irrespectively of the regimen used, although it has improved within years. Besides, treatment failure was more common in this region. Thus, improvements in the clinical management of HIV patients in EE are urgently needed. Strategies include creating scientific collaborations for HIV clinicians as well as teaching clinicians about the most advanced HIV management at clinically oriented courses held in eastern Europe.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080116-0098 - Epidemiološka i klinička obilježja zaraze HIV-om u Hrvatskoj (Begovac, Josip, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Josip Begovac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE